Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 48, Issue 5 (May 2010)

Issues

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

Niklas Mattsson
  • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Göteborg and Mölndal, Sweden
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Kaj Blennow
  • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Göteborg and Mölndal, Sweden
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Henrik Zetterberg
  • Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, University of Gothenburg, Göteborg and Mölndal, Sweden
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2010-03-05 | DOI: https://doi.org/10.1515/CCLM.2010.131

Abstract

Several drug candidates for Alzheimer's disease are being evaluated in clinical trials, with the goal of finding a drug with disease-modifying effects. When such a drug finally reaches the market, there will be a demand for accurate diagnostic tools useful for early detection of disease and for monitoring biochemical effects. The core cerebrospinal fluid (CSF) biomarkers amyloid peptides (Aβ42), total-tau and phospo-tau are promising in this respect. However, inter-center variation (caused by pre-analytical, analytical and post-analytical factors), and inter-laboratory variation (caused by analytical factors), particularly for CSF Aβ42, lowers their utility in multicenter studies. Here, we discuss the causes of these variations, and present a global quality control program to overcome them.

Clin Chem Lab Med 2010;48:603–7.

Keywords: Alzheimer's disease; amyloid; cerebrospinal fluid; quality control; variations

About the article

Corresponding author: Dr. Niklas Mattsson, Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital/Mölndal, 431 80 Mölndal, Sweden Phone: +46 31 3432377, Fax: +46 31 3432426,


Received: 2009-11-06

Accepted: 2010-01-08

Published Online: 2010-03-05

Published in Print: 2010-05-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2010.131.

Export Citation

©2010 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Min Shi, James Movius, Romel Dator, Patrick Aro, Yanchun Zhao, Catherine Pan, Xiangmin Lin, Theo K. Bammler, Tessandra Stewart, Cyrus P. Zabetian, Elaine R. Peskind, Shu-Ching Hu, Joseph F. Quinn, Douglas R. Galasko, and Jing Zhang
Molecular & Cellular Proteomics, 2015, Volume 14, Number 3, Page 544
[2]
Orestes V. Forlenza, Breno S. Diniz, Antonio L. Teixeira, Florindo Stella, and Wagner Gattaz
Revista Brasileira de Psiquiatria, 2013, Volume 35, Number 3, Page 284
[3]
Anne-Marie Miller, Aleksandra Rutkowska, Justyna M Bahl, Sanna-Kaisa Herukka, Marleen JA Koel-Simmelink, Niels Kruse, Brit Mollenhauer, Maritta Siloaho, Anders Skinningsrud, Henrik Zetterberg, Charlotte E Teunissen, and Brian A Lawlor
Bioanalysis, 2016, Volume 8, Number 21, Page 2243
[4]
Orestes V Forlenza, Breno S Diniz, and Wagner F Gattaz
BMC Medicine, 2010, Volume 8, Number 1
[5]
Daniel Bremell, Niklas Mattsson, Mikael Edsbagge, Kaj Blennow, Ulf Andreasson, Carsten Wikkelsö, Henrik Zetterberg, and Lars Hagberg
BMC Neurology, 2013, Volume 13, Number 1
[6]
Guro Berge, Camilla Lauridsen, Sigrid Botne Sando, Daniel Joseph Holder, Ina Møller, Jan Olav Aasly, Geir Bråthen, Mary Josephine Savage, and Linda Rosemary White
Journal of Alzheimer's Disease, 2015, Volume 49, Number 2, Page 493
[7]
Sara Galozzi, Katrin Marcus, and Katalin Barkovits
Expert Review of Proteomics, 2015, Volume 12, Number 4, Page 343
[8]
Mark E. Schmidt, Ping Chiao, Gregory Klein, Dawn Matthews, Lennart Thurfjell, Patricia E. Cole, Richard Margolin, Susan Landau, Norman L. Foster, N. Scott Mason, Susan De Santi, Joyce Suhy, Robert A. Koeppe, and William Jagust
Alzheimer's & Dementia, 2015, Volume 11, Number 9, Page 1050
[9]
Michael Ewers, Niklas Mattsson, Lennart Minthon, José L. Molinuevo, Anna Antonell, Julius Popp, Frank Jessen, Sanna-Kaisa Herukka, Hilka Soininen, Walter Maetzler, Thomas Leyhe, Katharina Bürger, Miyako Taniguchi, Katsuya Urakami, Simone Lista, Bruno Dubois, Kaj Blennow, and Harald Hampel
Alzheimer's & Dementia, 2015, Volume 11, Number 11, Page 1306
[10]
Flora H. Duits, Charlotte E. Teunissen, Femke H. Bouwman, Pieter-Jelle Visser, Niklas Mattsson, Henrik Zetterberg, Kaj Blennow, Oskar Hansson, Lennart Minthon, Niels Andreasen, Jan Marcusson, Anders Wallin, Marcel Olde Rikkert, Magda Tsolaki, Lucilla Parnetti, Sanna-Kaisa Herukka, Harald Hampel, Mony J. De Leon, Johannes Schröder, Dag Aarsland, Marinus A. Blankenstein, Philip Scheltens, and Wiesje M. van der Flier
Alzheimer's & Dementia, 2014, Volume 10, Number 6, Page 713
[11]
Antoine Leuzy, Eduardo Zimmer, Serge Gauthier, and Pedro Rosa-Neto
Translational Neuroscience, 2014, Volume 5, Number 1
[12]
Brit Mollenhauer, Joseph J Locascio, Walter Schulz-Schaeffer, Friederike Sixel-Döring, Claudia Trenkwalder, and Michael G Schlossmacher
The Lancet Neurology, 2011, Volume 10, Number 3, Page 230
[14]
Matthew T. White and Sharon X. Xie
Statistics in Medicine, 2013, Volume 32, Number 27, Page 4709
[15]
Mirjana Babić, Željka Vogrinc, Andrea Diana, Nataša Klepac, Fran Borovečki, Patrick Hof, and Goran Šimić
Translational Neuroscience, 2013, Volume 4, Number 2
[16]
Richard Dodel, Axel Rominger, Peter Bartenstein, Frederik Barkhof, Kaj Blennow, Stefan Förster, Yaroslav Winter, Jan-Philipp Bach, Julius Popp, Judith Alferink, Jens Wiltfang, Katharina Buerger, Markus Otto, Piero Antuono, Michael Jacoby, Ralph Richter, James Stevens, Isaac Melamed, Jerome Goldstein, Stefan Haag, Stefan Wietek, Martin Farlow, and Frank Jessen
The Lancet Neurology, 2013, Volume 12, Number 3, Page 233
[17]
Raymond L. Woosley
Annual Review of Pharmacology and Toxicology, 2013, Volume 53, Number 1, Page 255
[18]
Julien Dumurgier, Olivier Vercruysse, Claire Paquet, Stéphanie Bombois, Chloé Chaulet, Jean-Louis Laplanche, Katell Peoc’h, Susanna Schraen, Florence Pasquier, Jacques Touchon, Jacques Hugon, Sylvain Lehmann, and Audrey Gabelle
Alzheimer's & Dementia, 2013, Volume 9, Number 4, Page 406
[19]
Wesley Jongbloed, Maartje I. Kester, Wiesje M. van der Flier, Robert Veerhuis, Philip Scheltens, Marinus A. Blankenstein, and Charlotte E. Teunissen
Alzheimer's & Dementia, 2013, Volume 9, Number 3, Page 276
[20]
John Hardy
Journal of Neurochemistry, 2012, Volume 123, Number 3, Page 339
[21]
Henrik Zetterberg and Pieter Jelle Visser
Biomarkers in Medicine, 2012, Volume 6, Number 4, Page 363
[22]
Niklas Mattsson, Ulf Andreasson, Maria C Carrillo, Staffan Persson, Leslie M Shaw, Ingrid Zegers, Henrik Zetterberg, and Kaj Blennow
Biomarkers in Medicine, 2012, Volume 6, Number 4, Page 401
[23]
Niklas Mattsson, Ingrid Zegers, Ulf Andreasson, Maria Bjerke, Marinus A Blankenstein, Robert Bowser, Maria C Carrillo, Johan Gobom, Theresa Heath, Rand Jenkins, Andreas Jeromin, June Kaplow, Daniel Kidd, Omar F Laterza, Andrew Lockhart, Michael P Lunn, Robert L Martone, Kevin Mills, Josef Pannee, Marianne Ratcliffe, Leslie M Shaw, Adam J Simon, Holly Soares, Charlotte E Teunissen, Marcel M Verbeek, Robert M Umek, Hugo Vanderstichele, Henrik Zetterberg, Kaj Blennow, and Erik Portelius
Biomarkers in Medicine, 2012, Volume 6, Number 4, Page 409
[24]
Brit Mollenhauer and Jing Zhang
Movement Disorders, 2012, Volume 27, Number 5, Page 644
[25]
Piotr Lewczuk and Johannes Kornhuber
Expert Review of Proteomics, 2011, Volume 8, Number 4, Page 447
[26]
R L Woosley
Clinical Pharmacology & Therapeutics, 2012, Volume 91, Number 3, Page 390
[27]
C. Paquet, F. Latour, I. Saulnier, and O. Hanon
Revue Neurologique, 2012, Volume 168, Number 1, Page 28
[28]
William T. Hu, John Q. Trojanowski, and Leslie M. Shaw
Progress in Neurobiology, 2011, Volume 95, Number 4, Page 636
[29]
Martin Jenkins, Aiden Flynn, Trevor Smart, Chris Harbron, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis, and James Matcham
Pharmaceutical Statistics, 2011, Volume 10, Number 6, Page 494
[30]
Sara Bech, Lena E. Hjermind, Lisette Salvesen, Jørgen E. Nielsen, Niels H.H. Heegaard, Henrik L. Jørgensen, Lars Rosengren, Kaj Blennow, Henrik Zetterberg, and Kristian Winge
Parkinsonism & Related Disorders, 2012, Volume 18, Number 1, Page 69
[32]
R. Zimmermann, J. Kornhuber, and P. Lewczuk
Der Nervenarzt, 2011, Volume 82, Number 11, Page 1385
[34]
A. Petzold, N.A. Verwey, K. van Uffelen, M.A. Blankenstein, and C. Teunissen
Journal of Neuroscience Methods, 2010, Volume 193, Number 2, Page 296
[35]
Juan Fortea, Roser Sala-Llonch, David Bartrés-Faz, Albert Lladó, Cristina Solé-Padullés, Beatriz Bosch, Anna Antonell, Jaume Olives, Raquel Sanchez-Valle, Jose L. Molinuevo, and Lorena Rami
Biological Psychiatry, 2011, Volume 70, Number 2, Page 183
[36]
Giovanni B. Frisoni, Bengt Winblad, and John T. O'Brien
International Psychogeriatrics, 2011, Volume 23, Number 08, Page 1191
[37]
Niklas Mattsson, Henrik Zetterberg, and kaj Blennow
International Journal of Alzheimer's Disease, 2010, Volume 2010, Page 1
[38]
Giovanni B Frisoni, Harald Hampel, John T O'Brien, Karen Ritchie, and Bengt Winblad
The Lancet Neurology, 2011, Volume 10, Number 7, Page 598
[39]
Niklas Mattsson, Shahrzad Tabatabaei, Per Johansson, Oskar Hansson, Ulf Andreasson, Jan-Eric Månsson, Jan-Ove Johansson, Bob Olsson, Anders Wallin, Johan Svensson, Kaj Blennow, and Henrik Zetterberg
NeuroMolecular Medicine, 2011, Volume 13, Number 2, Page 151
[40]
Niklas Mattsson
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 3
[41]
Jakob Nyhlén, Radu Constantinescu, and Henrik Zetterberg
Biomarkers in Medicine, 2010, Volume 4, Number 5, Page 671
[42]
Brit Mollenhauer, Omar MA El-Agnaf, Katrin Marcus, Claudia Trenkwalder, and Michael G Schlossmacher
Biomarkers in Medicine, 2010, Volume 4, Number 5, Page 683
[43]
International Journal of Geriatric Psychiatry, 2010, Volume 25, Number 12, Page i

Comments (0)

Please log in or register to comment.
Log in